Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Rosenberg MT – For the patient with chronic pain requiring analgesic treatment for an extended period of time, long–acting analgesics are recommended. Theoretically, these agents will provide sustained analgesia by minimising the end–of–dose pain that is often seen with short–acting medications, with improved patient convenience and a potential for reduced risk of adverse events. The extended–release formulation of tramadol (tramadol ER) has proven efficacy in chronic pain conditions such as osteoarthritis and low back pain, as well as a favourable tolerability profile. In addition, tramadol ER has been shown in clinical trials to improve pain–related sleep disturbances and physical function in patients with chronic pain from osteoarthritis and low back pain.

Related Articles

Prognosis for patients with chronic low back pain: inception cohort study
British Medical Journal, 10/09/09    Relevance Score: 85%

Magnetic Resonance Imaging And Low Back Pain Care For Medicare Patients
Health Affairs, 11/06/09    Relevance Score: 83%

Causes and prevention of low back pain in young athletes
Paediatrics & Child Health, 10/19/09    Relevance Score: 83%

Low back pain may be caused by disturbed pain regulation: A cross-sectional study in low back pain patients using tender point examination
European Journal of Pain, 10/08/09    Relevance Score: 83%

Socioeconomic position and low-back pain – the role of biomechanical strains and psychosocial work factors in the GAZEL cohort
Scandinavian Journal of Work, Environment & Health, 10/08/09    Relevance Score: 83%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address